Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids-Reference-Cited by-同舟云学术

Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids

Published:2019-02-27 Issue:10 Volume:47 Page:e55-e55
ISSN:0305-1048
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Killian Tobias¹,Buntz Annette¹,Herlet Teresa¹,Seul Heike¹,Mundigl Olaf¹,Längst Gernot²,Brinkmann Ulrich¹

Affiliation:

1. Roche Pharma Research and Early Development (pRED), Therapeutic Modalities - Large Molecule Research, Roche Innovation Center Munich, Nonnenwald 2, D-82377 Penzberg, Germany

2. Biochemistry III; Biochemistry Centre Regensburg (BCR), University of Regensburg, Regensburg, Germany

Funder

Roche Postdoc Fund

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/47/10/e55/28761650/gkz137.pdf

Reference95 articles.

1. The basic science of gene therapy;Mulligan;Science,1993

2. Genome-editing technologies for gene and cell therapy;Maeder;Mol. Ther.,2016

3. Clinical development of gene therapy: results and lessons from recent successes;Kumar;Mol. Ther. Methods Clin. Dev.,2016

4. Gene therapy comes of age;Dunbar;Science,2018

5. Gene therapy on the move;Kaufmann;EMBO Mol. Med.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer;Biomaterials;2024-09

2. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy;Advanced Materials;2023-12-12

3. A temporally resolved DNA framework state machine in living cells;Nature Machine Intelligence;2023-08-14

4. Gene Reprogramming Armed Macrophage Membrane-Camouflaged Nanoplatform Enhances Bionic Targeted Drug Delivery to Solid Tumor for Synergistic Therapy;Molecular Pharmaceutics;2023-03-29

5. Non-viral delivery of the CRISPR/Cas system: DNAversusRNAversusRNP;Biomaterials Science;2022